$39.210
-0.651 (-1.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HRMY Prediction & Forecast by Similar Chart Analysis
Alphio's HRMY stock price prediction model matches the current Harmony Biosciences Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $38.99 (-0.56%). The 1-week path is $39.73 (+1.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Harmony Biosciences Holdings Inc Stock?
Harmony Biosciences appears to be a good buy right now due to its strong recent earnings performance, with a Q2 EPS of $1.28 that exceeded expectations by $0.32, and a significant revenue growth of 30.3% year-over-year, reaching $261.3 million. Additionally, the forward P/E ratio stands at 10.55, indicating potential for growth compared to its current price of $39.21. The main risk is the ongoing intellectual property litigation, which could impact future performance.
HRMY stock price ended at $39.21 on Friday, after losing -1.66%
Harmony Biosciences Holdings Inc (HRMY) last closed at $39.21, losing -1.66%. These facts feed the 1-day and 1-week HRMY price prediction above.
Forecast Drivers
Harmony Biosciences Holdings Inc (HRMY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches HRMY, ranked by similarity.
Seasonality analysis for HRMY
Historically the probability of a positive August return for HRMY is 90.48%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HRMY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $36.67 | $43.80 | $46.45 | +11.71% |
| Sep 2026 | $42.72 | $42.91 | $47.28 | +9.44% |
| Oct 2026 | $42.18 | $45.99 | $54.47 | +17.28% |
| Nov 2026 | $27.94 | $35.57 | $41.63 | -9.28% |
| Dec 2026 | $36.30 | $45.26 | $52.23 | +15.42% |
In 2026, Harmony Biosciences Holdings Inc (HRMY) is projected to range from $27.94 to $54.47.
Harmony Biosciences Holdings Inc 2026 monthly forecast
In Aug 2026, Harmony Biosciences Holdings Inc is projected to average $43.80, with a low of $36.67 and high of $46.45.
In Sep 2026, Harmony Biosciences Holdings Inc is projected to average $42.91, with a low of $42.72 and high of $47.28.
In Oct 2026, Harmony Biosciences Holdings Inc is projected to average $45.99, with a low of $42.18 and high of $54.47.
In Nov 2026, Harmony Biosciences Holdings Inc is projected to average $35.57, with a low of $27.94 and high of $41.63.
In Dec 2026, Harmony Biosciences Holdings Inc is projected to average $45.26, with a low of $36.30 and high of $52.23.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.